Snowball logo
logo
TBP_logo

Tetra Bio Pharma Inc

CA$0.025CA$0.00  (0%)
Estimate
EPS
-0.08
Beta
2.198
About the company
Ticker
TBP
ISIN
CA88166Y1007
Country
Canada
Sector (GICS)
Healthcare
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.

Frequently asked questions

What sector does Tetra Bio Pharma Inc (TBP) operate in?

Tetra Bio Pharma Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Tetra Bio Pharma Inc (TBP) current stock price?

As of the latest data, Tetra Bio Pharma Inc stock price is CA$0.03, with a previous close of CA$0.03.

What is Tetra Bio Pharma Inc (TBP) current market capitalization?

Tetra Bio Pharma Inc market cap is approximately 10.58 million.

What is Tetra Bio Pharma Inc (TBP) Earnings Per Share (EPS)?

The trailing EPS is -CA$0.08.

Does Tetra Bio Pharma Inc (TBP) pay dividends?

No. Tetra Bio Pharma Inc does not pay a dividend.

What is Tetra Bio Pharma Inc (TBP) beta (volatility) score?

Tetra Bio Pharma Inc has a beta of 2.198, indicating very high volatility compared to the market.